Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 203

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study

Open access
Lata, Sneh, Marasa, Maddalena, Li, Yifu, Fasel, David A., Groopman, Emily, Jobanputra, Vaidehi, Rasouly, Hila, Mitrotti, Adele, Westland, Rik, Verbitsky, Miguel, Nestor, Jordan, Slater, Lindsey M., D'Agati, Vivette, Zaniew, Marcin, Materna-Kiryluk, Anna, Lugani, Francesca, Caridi, Gianluca, Rampoldi, Luca, Mattoo, Aditya, Newton, Chad A., Rao, Maya K., Radhakrishnan, Jai, Ahn, Wooin, Canetta, Pietro A., Bomback, Andrew S., Appel, Gerald B., Antignac, Corinne, Markowitz, Glen S., Garcia, Christine K., Kiryluk, Krzysztof, Sanna-Cherchi, Simone, Gharavi, Ali G. · 2018 · Annals of Internal Medicine

Abstract

Background: The utility of whole-exome sequencing (WES) for the diagnosis and management of adult-onset constitutional disorders has not been adequately studied. Genetic diagnostics may be advantageous in adults with chronic kidney disease (CKD), in whom the cause of kidney failure often remains unknown. Objective: To study the diagnostic utility of WES in a selected referral population of adults with CKD. Design: Observational cohort. Setting: A major academic medical center. Patients: 92 adults with CKD of unknown cause or familial nephropathy or hypertension. Measurements: The diagnostic yield of WES and its potential effect on clinical management. Results: Whole-exome sequencing provided a diagnosis in 22 of 92 patients (24%), including 9 probands with CKD of unknown cause and encompassing 13 distinct genetic disorders. Among these, loss-of-function mutations were identified in PARN in 2 probands with tubulointerstitial fibrosis. PARN mutations have been implicated in a short telomere syndrome characterized by lung, bone marrow, and liver fibrosis; these findings extend the phenotype of PARN mutations to renal fibrosis. In addition, review of the American College of Medical Genetics actionable genes identified a pathogenic BRCA2 mutation in a proband who was diagnosed with breast cancer on follow-up. The results affected clinical management in most identified cases, including initiation of targeted surveillance, familial screening to guide donor selection for transplantation, and changes in therapy. Limitation: The small sample size and recruitment at a tertiary care academic center limit generalizability of findings among the broader CKD population. Conclusion: Whole-exome sequencing identified diagnostic mutations in a substantial number of adults with CKD of many causes. Further study of the utility of WES in the evaluation and care of patients with CKD in additional settings is warranted. Primary Funding Source: New York State Empire Clinical Research Investigator Program, Renal Research Institute, and National Human Genome Research Institute of the National Institutes of Health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m17-1319

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 203

Metadata

Authors
Lata, S., Marasa, M., Li, Y., Fasel, D. A., Groopman, E., Jobanputra, V., Rasouly, H., Mitrotti, A., Westland, R., Verbitsky, M., Nestor, J., Slater, L. M., D'Agati, V., Zaniew, M., Materna-Kiryluk, A., Lugani, F., Caridi, G., Rampoldi, L., Mattoo, A., Newton, C. A., Rao, M. K., Radhakrishnan, J., Ahn, W., Canetta, P. A., Bomback, A. S., Appel, G. B., Antignac, C., Markowitz, G. S., Garcia, C. K., Kiryluk, K., Sanna-Cherchi, S., & Gharavi, A. G.
Venue
Annals of Internal Medicine
Published
2018-01-16
Volume
168
Issue
2
Pages
100-109
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2783075063
Cited by
203
References
18
FWCI
13.60
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.